secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2023-07-05T23:59:59+00:00
Accession:  0001493152-23-023428
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity FY23 revenue up 26% to $9.64M, net loss narrows; 1:6 reverse split effective July 3
--------------------------------------------------------------------------------

- FY23 revenue grew 26% YoY to $9.64M; net loss decreased 35% to $19.5M.
- Recurring Technology Fees rose 49% to $8.8M, 71% gross margin; blended margin 57%.
- Q4 revenue $2.74M (+28% YoY); net loss $4.9M vs $6.0M a year ago.
- 1-for-6 reverse split to maintain Nasdaq $1 minimum bid; shares reduce to ~8.5M.
- Company targets positive cash flow by end of CY2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315223023428/0001493152-23-023428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315223023428/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-023428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer